Rivastigmine in the treatment of Huntington's disease [4]

European Journal of Neurology

Volumn 9, Issue 6, 2002, Pages 689-690

  Rot, Uroš ^a   Kobal, J ^a   Sever, A ^a   Pirtosek Z ^a   Mesec, A ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Acetylcholinesterase inhibitors; Huntington's disease; Rivastigmine; Treatment

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ACYLTRANSFERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; MUSCARINIC M1 RECEPTOR; RIVASTIGMINE; CARBAMIC ACID DERIVATIVE;

ADULT; BEHAVIOR DISORDER; CASE REPORT; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; LETTER; MALE; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; NUCLEUS ACCUMBENS; PARANOIA; PRIORITY JOURNAL; PSYCHOLOGIC TEST;

CARBAMATES; CHOLINESTERASE INHIBITORS; HUMANS; HUNTINGTON DISEASE; PHENYLCARBAMATES;

EID: 0036834904     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2002.00447_4.x     Document Type: Letter

References (12)

1. Fernandez HH, Friedman JH, Grace J, Beason-Hazen S (2000). Donepezil for Huntington's disease. Mov Disord 15:173-176.
2. Ferrante RJ, Beal MF, Kowall NW, Richardson EP Jr, Martin JB (1987). Sparing of acetylcholinesterase containing striatal neurons in Huntington's disease. Brain Res 411:162-166.
3. Francis PT, Palmer AM, Snape M, Wilcock GK (1999). The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 66:137-147.
4. Grace J, Daniel S, Stevens T et al. (2001). Long-term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial. Int Psychogeriatr 13:199-205.
5. Huntington Study Group (1996). Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 13:136-142.
6. Kanazawa I, Sasaki H, Muramoto O et al. (1985). Studies on neurotransmiter markers and striatal neuron density in Huntington's disease and dentatorubropallidoluysian atrophy. J Neurol Sci 70:151-165.
7. Lange KW, Javoy-Agid F, Agid Y, Jenner P, Marsden CD (1992). Brain muscarinic cholinergic receptors in Huntington's disease. J Neurol 239:103-104.
8. Martin JB (1984). Huntington's disease: new approaches to an old problem. Neurology 34:1059-1072.
9. Pirtošek Z, Jahanshahi M, Barrett G, Lees AJ (2001). Attention and cognition in bradykinetic-rigid syndromes: an event-related potential study. Ann Neurol 50:567-573.
10. Reading PJ, Luce AK, McKeith IG (2001). Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial. Mov Disord 16:1171-1174.
11. Roesler M, Anand R, Cicin-Sain A et al. (1999). Efficacy and safety of rivastimine in patients with Alzheimer's disease: international randomised controlled trial. BMJ 318:633-638.
12. Spokes EG (1980). Neurochemical alterations in Huntington's chorea: a study on post-mortem brain tissue. Brain 103:179-210.